Biotech
Regulatory
Regeneron and Sanofi’s Libtayo (cemiplimab) Receives European Commission’s Approval for
Shots: The conditional marketing authorization is based on the results from P-II EMPOWER-CSCC-1 (Study 1540) and supported by two advanced CSCC expansion cohorts from P-I study evaluating a Libtayo in […]readmore